Is Tencent Winding Down Its Big Investments?
A report that the tech giant is looking to sell its Meituan stake is stoking concerns of more similar divestments to come Key Takeaways: Reuters reported Tencent might sell some…
Viva Biotech Dispenses Bitter Pill of Slowing Growth, Asset Devaluation
The contract drug services provider lost roughly 100 million yuan in the first half of this year, as its revenue growth underperformed its peers Key Takeaways: Viva Biotech’s eked out…